These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1440 related items for PubMed ID: 23855299

  • 1. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
    Schuppan D, Schattenberg JM.
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
    [Abstract] [Full Text] [Related]

  • 2. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 3. Role of diet and nutritional management in non-alcoholic fatty liver disease.
    Fan JG, Cao HX.
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
    [Abstract] [Full Text] [Related]

  • 4. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 5. Non-alcoholic fatty liver disease.
    Smith BW, Adams LA.
    Crit Rev Clin Lab Sci; 2011 Jun; 48(3):97-113. PubMed ID: 21875310
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of non-alcoholic fatty liver disease].
    Koek GH.
    Ned Tijdschr Geneeskd; 2011 Jun; 155():A3181. PubMed ID: 21649947
    [Abstract] [Full Text] [Related]

  • 7. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
    Larter CZ, Chitturi S, Heydet D, Farrell GC.
    J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
    [Abstract] [Full Text] [Related]

  • 8. Non-alcoholic fatty liver disease.
    Tuyama AC, Chang CY.
    J Diabetes; 2012 Sep; 4(3):266-80. PubMed ID: 22564417
    [Abstract] [Full Text] [Related]

  • 9. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH.
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [Abstract] [Full Text] [Related]

  • 10. The epidemiology, pathogenesis and histopathology of fatty liver disease.
    Levene AP, Goldin RD.
    Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
    [Abstract] [Full Text] [Related]

  • 11. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H, Moschen A.
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [Abstract] [Full Text] [Related]

  • 12. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K.
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [Abstract] [Full Text] [Related]

  • 13. Non-alcoholic fatty liver disease from pathogenesis to management: an update.
    Musso G, Gambino R, Cassader M.
    Obes Rev; 2010 Jun; 11(6):430-45. PubMed ID: 19845871
    [Abstract] [Full Text] [Related]

  • 14. Non-alcoholic fatty liver disease.
    Leclercq I.
    Bull Mem Acad R Med Belg; 2010 Jun; 165(3-4):147-55; discussion 155-8. PubMed ID: 21166266
    [Abstract] [Full Text] [Related]

  • 15. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.
    Milić S, Stimac D.
    Dig Dis; 2012 Jun; 30(2):158-62. PubMed ID: 22722431
    [Abstract] [Full Text] [Related]

  • 16. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of disease progression in nonalcoholic fatty liver disease.
    Jou J, Choi SS, Diehl AM.
    Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293
    [Abstract] [Full Text] [Related]

  • 18. [Non-alcoholic fatty liver].
    Tagle Arrospide M.
    Rev Gastroenterol Peru; 2003 Nov; 23(1):49-57. PubMed ID: 12768215
    [Abstract] [Full Text] [Related]

  • 19. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.
    Moore JB.
    Proc Nutr Soc; 2010 May; 69(2):211-20. PubMed ID: 20158939
    [Abstract] [Full Text] [Related]

  • 20. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.